Institutional Investor Sentiment About Catalent (NYSE:CTLT) Improved

November 15, 2017 - By Maria Brooks

 Institutional Investor Sentiment About Catalent (NYSE:CTLT)  Improved

Sentiment for Catalent (NYSE:CTLT)

Catalent (NYSE:CTLT) institutional sentiment increased to 2.13 in Q2 2017. Its up 0.71, from 1.42 in 2017Q1. The ratio is better, as 145 investment professionals increased or started new positions, while 68 sold and trimmed stock positions in Catalent. The investment professionals in our partner’s database now have: 123.80 million shares, down from 126.34 million shares in 2017Q1. Also, the number of investment professionals holding Catalent in their top 10 positions was flat from 1 to 1 for the same number . Sold All: 18 Reduced: 50 Increased: 94 New Position: 51.

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. The company has market cap of $4.95 billion. The Company’s divisions include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. It has a 43.48 P/E ratio. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

The stock increased 0.03% or $0.01 on November 14, reaching $37.27. About shares traded. Catalent Inc (NYSE:CTLT) has risen 27.19% since November 15, 2016 and is uptrending. It has outperformed by 10.49% the S&P500.

Analysts expect Catalent Inc (NYSE:CTLT) to report $0.31 EPS on February, 5.They anticipate $0.07 EPS change or 29.17 % from last quarter’s $0.24 EPS. CTLT’s profit would be $41.17M giving it 30.06 P/E if the $0.31 EPS is correct. After having $0.18 EPS previously, Catalent Inc’s analysts see 72.22 % EPS growth.

Bernzott Capital Advisors holds 4.81% of its portfolio in Catalent Inc for 831,810 shares. Broadview Advisors Llc owns 256,663 shares or 1.33% of their US portfolio. Moreover, Norris Perne & French Llp Mi has 1.25% invested in the company for 285,495 shares. The New York-based Atika Capital Management Llc has invested 1.02% in the stock. Earnest Partners Llc, a Georgia-based fund reported 2.56 million shares.#img1#

Catalent Inc (NYSE:CTLT) Ratings Coverage

Ratings analysis reveals 54% of Catalent’s analysts are positive. Out of 13 Wall Street analysts rating Catalent, 7 give it “Buy”, 0 “Sell” rating, while 6 recommend “Hold”. The lowest target is $28 while the high is $45.0. The stock’s average target of $37.90 is 1.69% above today’s ($37.27) share price. CTLT was included in 28 notes of analysts from September 3, 2015. Jefferies maintained the shares of CTLT in report on Monday, August 21 with “Hold” rating. The firm has “Sector Weight” rating given on Friday, September 8 by KeyBanc Capital Markets. Jefferies maintained the shares of CTLT in report on Monday, August 28 with “Hold” rating. The rating was maintained by Jefferies with “Hold” on Monday, June 26. Piper Jaffray maintained the shares of CTLT in report on Tuesday, August 29 with “Buy” rating. The company was downgraded on Tuesday, December 22 by Wells Fargo. The firm has “Buy” rating given on Tuesday, August 29 by Bank of America. The firm earned “Mkt Perform” rating on Wednesday, December 9 by Raymond James. The stock of Catalent Inc (NYSE:CTLT) has “Overweight” rating given on Thursday, October 20 by KeyBanc Capital Markets. Bank of America maintained the shares of CTLT in report on Wednesday, September 20 with “Buy” rating.

More notable recent Catalent Inc (NYSE:CTLT) news were published by: which released: “Cook Group Completes Sale of Cook Pharmica” on October 24, 2017, also with their article: “Catalent, Inc. Reports First Quarter Fiscal 2018 Results” published on November 06, 2017, published: “Catalent Completes Repricing and Extension of Credit Agreement” on October 18, 2017. More interesting news about Catalent Inc (NYSE:CTLT) were released by: and their article: “Catalent, Inc. Announces First Quarter Fiscal Year 2018 Earnings Conference …” published on October 19, 2017 as well as‘s news article titled: “Catalent, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference” with publication date: November 14, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.